TITLE

An unusual cystic lung lesion

AUTHOR(S)
Huang, T-W.; Cheng, Y.L.; Lee, S-C.
PUB. DATE
November 2008
SOURCE
Thorax;Nov2008, Vol. 63 Issue 11, p980
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
A quiz about an unusual cystic lung lesion is presented.
ACCESSION #
35420160

 

Related Articles

  • Reasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment. Yammine, Sophie; Bigler, Anja; Casaulta, Carmen; Singer, Florian; Latzin, Philipp; Horsley, Alex // Thorax;Feb2014, Vol. 69 Issue 2, p183 

    A letter to the editor and a response from the author of the article is presented titled "Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation" in 2013 issue.

  • Highlights from this issue. Andrew Bush; Ian Pavord // Thorax;Oct2011, Vol. 66 Issue 10, pi 

    The article discusses various reports published within the issue on topics including lungs attacks in cystic fibrosis patients, lung transplantation and lung cancer screening.

  • 12th Annual North American Cystic Fibrosis Conference October 15-18, 1998, Montreal, Canada. Cowley, Elizabeth A. // Clinical & Investigative Medicine;Feb99, Vol. 22 Issue 1, p26 

    Presents the 12th Annual North American Cystic Fibrosis (CF) Conference in Montreal, Canada, which revealed the latest advances in every aspect of CF disease. Pathogenesis of CF lung disease; Treatment of CF pulmonary disease; Cause of CF.

  • Treatment of Cystic Fibrosis in Adults. Hamer, Louis; Parker, Henry Worth // American Family Physician;9/15/1996, Vol. 54 Issue 4, p1291 

    Describes cystic fibrosis in adults. Genetics; Pathophysiology; Clinical manifestations; Diagnosis; Complications; Evaluation and treatment; New therapies.

  • Expression of S100A12 (EN-RAGE) in cystic fibrosis. Foell, D.; Seeliger, S.; Vogl, T.; Koch, H.-G.; Maschek, H.; Harms, E.; Sorg, C.; Roth, J. // Thorax;Jul2003, Vol. 58 Issue 7, p613 

    Background: Chronic airway inflammation and recurrent infections are a core phenomenon in cystic fibrosis (CF). Diagnosing acute infectious exacerbations is difficult in the presence of chronic inflammatory processes. S100A12 exhibits proinflammatory functions via interaction with the...

  • Volumetric capnography as a tool to detect early peripheric lung obstruction in cystic fibrosis patients. Ribeiro, Maria Ângela G. O.; Silva, Marcos T. N.; Ribeiro, José Dirceu; Moreira, Marcos M.; Almeida, Celize C. B.; Almeida-Junior, Armando A.; Ribeiro, Antonio F.; Pereira, Monica C.; Hessel, Gabriel; Paschoal, Ilma A. // Jornal de Pediatria;Nov/Dec2012, Vol. 88 Issue 6, p509 

    Objective: To compare spirometry and volumetric capnography (VCap) to determine if the capnographic values add more information about early lung disease in cystic fibrosis (CF) patients. Methods: This was a cross-sectional study involving CF patients: Group I (42 patients, 6-12 years of age);...

  • Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments. Brugha, Rossa E; Davies, Jane C // British Journal of Hospital Medicine (17508460);Nov2011, Vol. 72 Issue 11, p614 

    The article offers information on cystic fibrosis, and discusses the pathogenic mechanisms of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. It explains how the organism P. aeruginosa establishes an infection and develops into a biofilm. The article also discusses the new...

  • Cystic fibrosis gene mutations: evaluation and assessment of disease severity. Vallières, Emilie; Elborn, Joseph Stuart // Advances in Genomics & Genetics;2014, Vol. 4, p161 

    The cystic fibrosis transmembrane regulator (CFTR) gene encodes an ion channel transporter, the CFTR protein. Since its identification in 1989, more than 1,900 sequence variants have been reported, resulting in a wide spectrum of clinical phenotypes. Cystic fibrosis (CF) is associated with many...

  • An Unexpected Reprieve. Whitford, Ben // Newsweek (Pacific Edition);9/12/2005 (Pacific Edition), Vol. 146 Issue 11, p48 

    Discusses new treatments for cystic fibrosis (CF) which can extend patients' life spans from months to years and from years to decades. Background on the lethal genetic disorder; The extended life span of today's CF patients which stems not from a single breakthrough but from a stream of minor...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics